AVERITAS PHARMA
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Jun 2025)
What this means for you
This application is over — abandoned 23 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97381068
- Mark type
- Stylized text
- Filed
- 26 Apr 2022
- Published for opposition
- 28 Mar 2023
- Abandoned
- 23 Jun 2025
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of inflammation and gout; vaccines; sanitary preparations for medical purposes; dietetic substances to support nutritional balance and to treat deficiencies, namely, vitamins, mineral supplements, and probiotic preparations adapted for medical use; Wound dressings; surgical dressings; bandages, medical adhesive patches and medical adhesive tapes for dressings; medical adhesives to bind wounds; bandages, medical adhesive patches, medical adhesive tapes and medical adhesives to close skin wounds, incisions and cuts
- Class 041 — Education and entertainment services: Conducting of training courses in the field of medicine and pharmaceuticals; issuance and publication of books, journals and other communication media in print and electronic form, namely, publishing and issuing of books, journals and scientific papers in the field of medicine and pharmaceuticals, especially for pharmaceutical companies, pharmacists, physicians, patients, health insurance companies and their professional associations
- Class 042 — Scientific and technological services: Scientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development, product development of medical devices, development of healthcare software, development of healthcare informatics services and scientific study and research services in the fields of medicine and the prevention, treatment and management of illnesses, diseases and disorders
Owner
- Averitas Pharma, Inc., Morristown, NJ, US
- Averitas Pharma, Inc., Morristown, NJ, US
Prior registrations
Prosecution history
- 23 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 05 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2024 — SOU EXTENSION 3 GRANTED
- 20 Nov 2024 — SOU EXTENSION 3 FILED
- 20 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2024 — CORRECTED NOA E-MAILED
- 13 Aug 2024 — DIVISIONAL PROCESSING COMPLETE
- 02 May 2024 — DIVISIONAL REQUEST RECEIVED
- 07 Aug 2024 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 07 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Aug 2024 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 11 Jun 2024 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 10 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED